Interleukin-6 receptor subunit alpha
| Position | Description |
|---|---|
| 245 | Not glycosylated |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 55 | N-linked (GlcNAc...) asparagine |
|
||
| 93 | N-linked (GlcNAc...) asparagine | |||
| 139 |
|
|
||
| 197 |
|
|||
| 221 | N-linked (GlcNAc...) asparagine |
|
||
| 245 | N-linked (GlcNAc...) asparagine |
|
||
| 320 |
|
|||
| 329 |
|
|||
| 335 |
|
|||
| 350 | N-linked (GlcNAc...) asparagine |
|
| Pathway Name | Organism |
|---|---|
| Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
| Interleukin-6 signaling | Homo sapiens |
| MAPK1 (ERK2) activation | Homo sapiens |
| MAPK3 (ERK1) activation | Homo sapiens |
| Potential therapeutics for SARS | Homo sapiens |
| Transcriptional regulation of granulopoiesis | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080545 | hyper IgE syndrome | |
| DOID:10534 | stomach cancer | |
| DOID:10652 | Alzheimer's disease | |
| DOID:12858 | Huntington's disease | |
| DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025